AI
ANGO icon

Atom Investors’s AngioDynamics ANGO Stock Holding History

Atom Investors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-21,156
Closed -$272K – 655
2025
Q4 		$272K Sell
21,156
-14,703
-41% -$181K 0.02% 456
2025
Q3 		$401K Buy
35,859
+13,832
+63% +$133K 0.03% 396
2025
Q2 		$219K Buy
+22,027
New +$216K 0.02% 498
2025
Q1 		– Sell
-11,010
Closed -$101K – 497
2024
Q4 		$101K Sell
11,010
-3,640
-25% -$26.8K 0.01% 451
2024
Q3 		$114K Sell
14,650
-2,862
-16% -$20.7K 0.01% 435
2024
Q2 		$106K Sell
17,512
-41,489
-70% -$256K 0.01% 443
2024
Q1 		$346K Buy
+59,001
New +$351K 0.04% 389
2019
Q1 		– Sell
-15,623
Closed -$314K – 506
2018
Q4 		$314K Buy
+15,623
New +$323K 0.03% 472

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
WCM
Weber Capital Management San Francisco, California $100M AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAM
Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Atom Investors's ANGO Position: Q1 2026 in Review

Atom Investors sold out of AngioDynamics (ANGO) in Q1 2026, closing a stake of 21,156 shares — an estimated $272K sold.

Atom Investors first reported a position in ANGO in Q4 2018 and held it in 8 quarters. The position peaked at $401K in Q3 2025. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Atom Investors reported no remaining AngioDynamics position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 21,156 AngioDynamics shares in Q1 2026, an estimated $272K.
  • Atom Investors first reported a position in AngioDynamics in Q4 2018 and held it in 8 quarters.
  • Atom Investors's AngioDynamics position peaked at $401K in Q3 2025.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.